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As populations grow, greater effort is made to understand
the political and economic impact of ageing. Understand-
ing the pathophysiology of this degenerative process has
engendered no less effort or interest. At the subcellular
and molecular level, ageing heralds changes in the
balance between DNA damage and repair, changes in the
frequency of somatic mutations, as well as deterioration in
the functional integrity of mitochondria and its own DNA
[1]. At a cellular level, these changes can manifest as
clonal expansions driven by a strong survival advantage,
and in some cases as malignant transformation. Recent
events in the cloning arena have forced scientists and
physicians to reflect upon the potential impact of somatic
cell nuclear transfer. What is the impact of genetic chi-
maerism? Does it accelerate ageing? What are the mech-
anisms, and at what level do they work? Readers of
Arthritis Research & Therapy must be particularly curious
to know why Dolly the sheep, the first mammal to be
cloned from an established adult somatic cell, subse-
quently developed arthritis [2]. We have yet to find the
answer to these important questions.
It has long been recognised that there exists a relationship
between ageing and susceptibility to infection. It follows
from this that defects in the ageing immune system must
somehow be to blame. Quite how the immune system
ages, and how immune senescence predisposes individu-
als to disease is still a mystery. Nevertheless, advances in
basic cell biology and a better appreciation of how cells
integrate and respond to signals acquired from their envi-
ronment has made it possible to piece together aberra-
tions of the ageing immune system, largely at the cellular
level. New laboratory techniques are at our disposal, and
these have most certainly facilitated progress. For
example, we can now study thymic function, or perhaps
more accurately newly generated T cells [3], and we can
also utilise biomarkers to define specific cell subsets and
correlate genotype and phenotype with function. Particu-
larly important for studying ageing is an appreciation of
replicative history and proliferative senescence made pos-
sible by the capacity to directly measure it, through analy-
sis of telomere length [4]. And of course a list of
experimental approaches wouldn’t be complete without
mentioning gene expression profiling.
Data suggest that while antigen presenting function is rel-
atively well preserved during the ageing process [5], lym-
phocyte function is perturbed, characterised by
depression of both cellular and humoral immunity. Accord-
ingly, to begin to address how ageing influences immunity,
a focus on lymphocyte biology seems a good starting
point. For example, over the decades numerous studies
have reported altered production of T cell progenitors,
reductions in the generation of naïve T cells, ageing of
resting and clonally expanding cells, and in particular dis-
rupted intracellular signalling leading to perturbations in
cytoskeleton reorganisation and cell migration [reviewed in
6]. In this issue, Goronzy and Weyand begin by exploring
how the dynamics of T cell repertoire diversity promote the
expansion of effector cells [7]. Through an analysis of the
expression of T cell receptor excision circles as surrogate
markers of recent thymic emigrants, together with assays
of telomerase activity, they have established models that
provide compelling evidence for premature immunosenes-
cence in patients with rheumatoid arthritis. Particularly
striking are the contractions of the T cell repertoire and,
through mechanisms likely to involve homeostatic prolifer-
ation, clonal expansions of potent effector T cells carrying
an unusual phenotype. The T cell theme continues in the
next issue, where Fülöp and Pawelec summarise a series
of remarkable defects in T cell antigen receptor signalling,
comparing and contrasting these anomalies with those
signalling defects reported in chronic inflammatory dis-
eases such as rheumatoid arthritis and systemic lupus ery-
thematosus [8]. They raise the intriguing possibility that
while T cell hyporesponsiveness to T cell antigen receptor
engagement is likely to impair host defense and tumour
immunity, such defects may also provoke autoimmunity. In
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the third review of the series, Johnson and Cambier
discuss age-related changes during B cell development,
emphasising the skewing in immunoglobulin variable
region usage as one possible mechanism for the suscepti-
bility of the ageing population to infection [9]. During
ageing there is also an associated decline in B cell devel-
opment in the bone marrow, the most significant being at
the transition of pro-B cells to pre-B cells, while in the
periphery, homeostatic proliferation drives the expansion
and accumulation of autoantibody secreting cells in the
follicular compartment. One cannot help but remark upon
the similarities between T cell and B cell developmental
defects, in this regard. Of particular interest, Johnson and
Cambier discuss prospects for reconstituting ageing
organisms with stem cells from younger individuals.
Despite the use of sophisticated laboratory tools to
uncover the perturbations of immune senescence, a
major challenge remaining will be to determine quite how
such aberrations translate to autoimmune disease in
general, but arthritis in particular. While giving due con-
sideration to each hypothesis, we must also consider the
potential evolutionary advantages of immunosenescence.
Do these perturbations reflect an adaptive response, gen-
erated over decades, to suppress inappropriate lympho-
cyte reactions to immunogenic, post-translationally
modified host tissue proteins subjected to decades of
environmental stress? If this is the case, one can envis-
age why the process of attenuation of T and B cell reac-
tivity might develop in accelerated form in younger
patients with inflammatory joint disease. As Goronzy and
Weyand state from the outset, exploring the immunobiol-
ogy of ageing could help us to understand the pathogen-
esis of chronic inflammatory syndromes, and more
importantly, to develop therapies that target these crip-
pling degenerative processes.
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